Dr Reddys Laboratories Ltd EPS

Dr Reddys Laboratories Ltd EPS

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

EPS

₹ 66.71

Last updated on: Apr 29, 2026

Key Highlights

  • The Earning per Share of Dr Reddys Laboratories Ltd is ₹ 66.71 as of 29 Apr 26 The earning per share of Dr Reddys Laboratories Ltd changed from ₹ 83.61 to ₹ 14.53 over 7 quarters. This represents a CAGR of -63.21% .

Historical Earning per Share of Dr Reddys Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Dr Reddys Laboratories Ltd

Market Cap

111,017 Cr

EPS

66.7

P/E Ratio (TTM)

19.9

P/B Ratio (TTM)

3.1

Day’s High

1340.0

Day’s Low

1314.6

DTE

0.2

ROE

16.0

52 Week High

1377.95

52 Week Low

1121.2

ROCE

18.7

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Apr 20261330.1
28 Apr 20261354.75
27 Apr 20261334.55
24 Apr 20261315.85
23 Apr 20261333.05
22 Apr 20261217
21 Apr 20261220.75
20 Apr 20261232.25
17 Apr 20261235.4
16 Apr 20261221.25

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Dr Reddys Laboratories Ltd

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

1,11,018

Asset Value

Value addition

3.7 X

23,733

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Dr Reddys Laboratories Ltd111017
Sun Pharmaceutical Industries Ltd426830
Divis Laboratories Ltd173484
Torrent Pharmaceuticals Ltd143166
Cipla Ltd106357
Lupin Ltd105650

Historical Market Cap of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Dr Reddys Laboratories Ltd News Hub

Dr Reddys Laboratories Ltd gains for third straight session

Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707

Read more

21 Aug 24

Dr Reddy's formulations manufacturing units receives EIR from USFDA

Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m

Read more

12 Aug 24

Dr Reddys allots 29,790 equity shares under ESOP

Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu

Read more

07 Aug 24

Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA

The inspection has been classified as voluntary action indicated (VAI) and has been closed according

Read more

06 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Aug 2024

Transcript

July 2024

Transcript

May 2024

Transcript

Feb 2024

Transcript

Nov 2023

Transcript

July 2023

TranscriptPPT

May 2023

Transcript

Jan 2023

Transcript

Nov 2022

Transcript

June 2022

TranscriptPPT

Feb 2022

Transcript

FAQs for EPS of Dr Reddys Laboratories Ltd

What is the EPS of Dr Reddys Laboratories Ltd stock?

The Earnings Per Share (EPS) of Dr Reddys Laboratories Ltd is 66.71. An EPS is the amount of net income attributed to each share of a common stock.

How is Dr Reddys Laboratories Ltd EPS calculated?

The EPS of Dr Reddys Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Dr Reddys Laboratories Ltd report its EPS?

Dr Reddys Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Dr Reddys Laboratories Ltd EPS?

Factors that influence the EPS of Dr Reddys Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Dr Reddys Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Dr Reddys Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions